Rosehip seed oil after CO2 laser for the management of facial scars

ISRCTN ISRCTN14338385
DOI https://doi.org/10.1186/ISRCTN14338385
Submission date
19/11/2024
Registration date
26/11/2024
Last edited
26/11/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Facial scars are a serious post-surgical complication that needs the attention of the health care system. This type of scars can affect the quality of life and self-esteem of the patient. Therefore, the aim of this study is to evaluate the effectiveness of using rosehip seed oil in the management of facial scars after surgical interventions.

Who can participate?
Adults aged 18 years or older who have a fresh post-surgical facial scar

What does the study involve?
The patients will be randomly assigned to one of the two intervention groups: the silicon cream group or the rosehip seed oil group. Both groups will receive fractional CO2 laser therapy for the management of post-surgical facial scars.

What are the possible benefits and risks of participating?
This study will determine the effectiveness of using rosehip seed oil in the management of facial scars. There is a risk of not achieving optimal results in some cases but the study team can manage these cases with alternative methods.

Where is the study run from?
Damascus University (Syria)

When is the study starting and how long is it expected to run for?
January 2024 to November 2024

Who is funding the study?
Damascus University (Syria)

Who is the main contact?
Dr Kamar Zwada (zwadakamar@gmail.com)

Contact information

Dr Kamar Zwada
Public, Scientific, Principal Investigator

Damascus, Syria
Damascus
0000
Syria

Phone +963 (0)998587787
Email zwadakamar@gmail.com

Study information

Study designComparative interventional randomized controlled study
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)University/medical school/dental school
Study typeQuality of life, Treatment
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleA comparison between silicone cream and rosehip seed oil after the application of fractional CO2 laser in the management of post-surgical facial scars
Study objectivesIs there a significant statistical difference between the use of rosehip seed oil and silicon cream after the use of CO2 laser in the management of post-surgical facial scars?
Ethics approval(s)

Approved 22/01/2024, Damascus University Ethics Committee (Damascus, Syria, Damascus, 0000, Syria; +963 (0)113341864; manager@hcsr.gov.sy), ref: 22457

Health condition(s) or problem(s) studiedFacial scar management
InterventionRandomization process: sealed envelope randomization method.

Protocol and duration of the treatments:
The patients were randomly assigned to one of the two study groups: the control group (silicon cream) and the test group (rosehip seed oil). All patients followed the same protocol, differing only at the final stage. The treatment involved applying a CO2 fractional laser to the scar tissue on the face.

Control group (silicon cream): silicon cream was applied to the scar in a thin layer.

Test group (rosehip seed oil): 2-3 drops of rosehip seed oil were applied to the scar and spread to cover the entire area.

After applying both treatments, an ice bag was used to cool the treated area. Patients in the control group were instructed to apply the silicon cream twice a day for 3 months, while patients in the test group were instructed to apply 2-3 drops of rosehip seed oil to the scar twice a day for 3 months. The fractional laser treatment was reapplied once a month for 3 months.

Follow-up: The follow-up session for all patients was scheduled 1 month after the last laser application session.
Intervention typeProcedure/Surgery
Primary outcome measureScar healing measured using the Vancouver Scar Scale (VSS) to evaluate the pigmentation, elasticity, and height of the scar, evaluated before the treatment and after 4 months
Secondary outcome measuresPatient satisfaction measured using a five-point Likert scale at 4 months after the procedure
Overall study start date07/01/2024
Completion date01/11/2024

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
Upper age limit45 Years
SexBoth
Target number of participants20
Total final enrolment20
Key inclusion criteria1. Patients are at least 18 years old
2. Fresh atrophic post-surgical facial scar
Key exclusion criteria1. Matured facial scars (3 months after its formation)
2. Facial scars not caused by facial surgery
3. Patients underwent treatment with retinoid in the last 6 months
Date of first enrolment01/02/2024
Date of final enrolment01/05/2024

Locations

Countries of recruitment

  • Syria

Study participating centre

Damascus University
Damascus
0000
Syria

Sponsor information

Damascus University
University/education

Damascus, Syria
Damascus
0000
Syria

Phone +963 (0)113341864
Email manager@hcsr.gov.sy
Website http://www.damascusuniversity.edu.sy
ROR logo "ROR" https://ror.org/03m098d13

Funders

Funder type

University/education

Damascus University
Government organisation / Universities (academic only)
Alternative name(s)
University of Damascus, جَامِعَةُ دِمَشْقَ, DU
Location
Syria

Results and Publications

Intention to publish date10/01/2025
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication of the research results
IPD sharing planThe datasets generated during and/or analyzed during the current study will be available on request from Dr Kamar Zwada (zwadakamar@gmail.com) and in the publication related to it after the end of the research.

Editorial Notes

19/11/2024: Study's existence confirmed by Damascus University.